Investigational Site Number : 250001

Villejuif 94805

0 studies enrolling now · 5 studies all time

What they study most

Hematopoietic Neoplasm, Malignant Solid Tumors, Neoplasm Malignant, Prostate Cancer

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Evaluation of SAR408701 in Patients With Advanced Solid Tumors — Stopped early
• Phase 1 Safety Testing of SAR405838 — Completed
• Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer — Completed
• Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors — Completed